The invention provides a method for screening a I type 17 beta-
hydroxysteroid dehydrogenase inhibitor through an 
immobilized enzyme, and belongs to the technical field of enzymology and 
enzyme engineering. I type 17 beta-
hydroxysteroid dehydrogenase (17 beta-HSD1) has the important function in treating 
hormone-dependent diseases. At present, a substrate radiolabelling method is mainly adopted in studying the activity of 17 beta-HSD1, due to the fact that the free 
enzyme of 17 beta-HSD1 is likely to be inactivated, 17 beta-HSD1 is hard to prepare, a fresh 
placenta is needed for preparing an 
enzyme source in a new 
medicine screening experiment of every time, raw materials are hard to obtain, the price is high, and difficulty is brought to the screening work of new 
medicine. According to the method, an amino-modified 
silicon ball is adopted as a carrier, a 
glutaraldehyde crosslinking method is utilized, 17 beta-HSD1 extracted from the 
placenta is fixed, an external immobilization 17 beta-HSD1 enzyme model is built, 
androstenedione is adopted as a substrate, a 
high performance liquid chromatography method is used for detecting products, and the potential 17 beta-HSD1 inhibitor is screened. According to the method, 
instability of the free enzyme is overcome, operation is easy, the manufacturing cost is low, and repeated using is achieved.